This website is intended for healthcare professionals

A greener NHS

A new survey conducted by conservation charity the Woodland Trust has revealed 96% of GPs questioned want the government to take action to combat health threats from climate change and extreme...

TIRZEPATIDE

Day 1: Following the diabetes & weight loss successes of GLP-1 agonists such as semaglutide, #tirzepatide is the 1st ‘dual’ incretin drug. Peptide engineering has been used to bring GLP-1 activity...

Use of genomic medicine to uncover adverse effects related to direct oral anticoagulants

Cardiac arrhythmias represent a significant burden, affecting morbidity and mortality (Gheorghe-Andrei et al, 2018). Atrial fibrillation (AF) is the most common arrhythmia, and prevalence not only...

UPDATES

The Joint Committee on Vaccination and Immunisation (JCVI) has announced its advice to government for the Covid-19 vaccine programme this year.

Prescribing in patients with diabetes

This article, published in the New Zealand Journal of Primary Healthcare, sought to undertake a review of the literature about the impact of nurse prescribing on the delivery of healthcare services...

Evaluation of factors influencing antibiotic prescribing behaviour by independent nurse prescribers

To establish the factors that influence INPs' antibiotic prescribing decisions, and to compare the responses between practice settings with factors that influence medical prescribers' antibiotic...

The role of nutrition in bipolar disorder

Loots et al (2021) note that psychiatric disorders comprise 13% of the total global disease burden, with non-adherence to medication ranging from 63–74% in patients with schizophrenia and some 50% in...

A–Z of prescribing for children

There is a continuing need for pharmaceutical companies to manufacture age-appropriate medications for children. It is not just preferences for particular formulations that need to be considered, but...

Prescribing medications for Parkinson's disease

Parkinsonism is an umbrella term for conditions that present with symptoms typically seen in Parkinson's disease (which accounts for around 85% of cases of parkinsonism) (McFarland and Hess, 2017;...

Safety in prescribing

Welcome to this February issue of the Journal of Prescribing Practice.

Oxybutynin

Day 1: #oxybutynin is an anti-muscarinic drug approved in 1970s for incontinence & overactive bladder. #oxybutynin remains a 1st-line drug in UK. Side effects, especially dry mouth can lead to...

Updates

The NHS has pledged to expand the number of training places for nursing associates to 10 500 by 2031/32, as part of wider plans for expansion across the nursing professions..

New treatment hopes for Alzheimer's disease: A look at recent drug trials

Eli Lilly (2023) created donanemab, noting last year that 47% of participants taking the medication had no clinical progression at one year of the disease. However, the placebo group also had no...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP